Should we use nintedanib as early therapy in patients with SSc-ILD?

Bibliographic Details
Title: Should we use nintedanib as early therapy in patients with SSc-ILD?
Authors: Zanatta, Elisabetta, Moccaldi, Beatrice, Szucs, Gabriella, Spagnolo, Paolo
Source: In Autoimmunity Reviews January 2024 23(1)
Database: ScienceDirect
More Details
ISSN:15689972
DOI:10.1016/j.autrev.2023.103463
Published in:Autoimmunity Reviews
Language:English